FdaApplication

ANDA 218597

Back to search

Identifiers

Properties

PropertyValue
applicant_nameGRAVITI PHARMACEUTICALS PRIVATE LTD
application_typeANDA
approval_date2025-07-24

Products (3)

ProductActive ingredientStrengthDosage form
LORAZEPAMLORAZEPAM1MGTABLET;ORAL
LORAZEPAMLORAZEPAM0.5MGTABLET;ORAL
LORAZEPAMLORAZEPAM2MGTABLET;ORAL

3 products